FSTX
F-Star Therapeutics Inc
Clinical-stage biopharmaceutical company focused on oncology immunotherapies
CUSIP: 30315R107HealthcareUS1 holder
Total Value
$311.7K
Total Shares
49.4K
Net Share Change
+25.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Fairfax Financial Holdings
$311.7K49.4K shares
ADD+25.0K(+102.5%)